2.28
-0.03(-1.30%)
Currency In USD
| Previous Close | 2.31 |
| Open | 2.28 |
| Day High | 2.3 |
| Day Low | 2.12 |
| 52-Week High | 162.5 |
| 52-Week Low | 2.18 |
| Volume | 266,117 |
| Average Volume | 86,235 |
| Market Cap | 1.82M |
| PE | -0.04 |
| EPS | -51.81 |
| Moving Average 50 Days | 4.7 |
| Moving Average 200 Days | 15.96 |
| Change | -0.03 |
If you invested $1000 in NanoVibronix, Inc. (NAOV) 10 years ago, it would be worth $2.5 as of January 14, 2026 at a share price of $2.28. Whereas If you bought $1000 worth of NanoVibronix, Inc. (NAOV) shares 5 years ago, it would be worth $9.97 as of January 14, 2026 at a share price of $2.28.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Data not available
ENvue Medical Launches Program to Address Patient Pain and Discomfort with Indwelling Nasogastric Tubes Based on Previously Published, Peer-Reviewed Clinical Research
GlobeNewswire Inc.
Jan 09, 2026 2:01 PM GMT
The program will integrate the Company’s clinically validated NanoVibronix technology to improve comfort associated with indwelling nasogastric tubesTYLER, Texas, Jan. 09, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (
ENvue Medical to Ring the Nasdaq Opening Bell on Wednesday, January 14th, 2026
GlobeNewswire Inc.
Jan 08, 2026 3:02 PM GMT
TYLER, Texas, Jan. 08, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in non-invasive therapeutic systems including enteral access so
ENvue Medical, Formerly NanoVibronix, UroShield® Kit Secures Reimbursement in the UK
GlobeNewswire Inc.
Dec 18, 2025 5:30 PM GMT
Peak Medical, ENvue’s Exclusive Distributor in UK, Places Significant Order after Reimbursement Decision, Projecting Future Market Demand for UroShield® KitTYLER, Texas, Dec. 18, 2025 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: